• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the requirements set forth by 18 U.S.C. 208 are met. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of December 31, 2014.

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetPercent Granted Waivers
Oct 2014N/A0
Nov 2014N/A0
Dec 2014N/A0
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 0%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2014N/A0
Nov 2014N/A0
Dec 2014N/A0
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 0

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2014N/A85
Nov 2014N/A127
Dec 2014N/A97
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 309

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.